39,976 Shares in LifeStance Health Group, Inc. (NASDAQ:LFST) Purchased by XTX Topco Ltd

XTX Topco Ltd acquired a new stake in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 39,976 shares of the company's stock, valued at approximately $295,000.

Other large investors also recently modified their holdings of the company. Blue Trust Inc. boosted its holdings in LifeStance Health Group by 124.4% in the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company's stock valued at $27,000 after purchasing an additional 2,122 shares during the last quarter. R Squared Ltd acquired a new position in shares of LifeStance Health Group in the 4th quarter valued at approximately $80,000. Cibc World Markets Corp acquired a new stake in shares of LifeStance Health Group during the fourth quarter worth approximately $96,000. Handelsbanken Fonder AB acquired a new stake in shares of LifeStance Health Group during the fourth quarter worth approximately $128,000. Finally, Versor Investments LP bought a new stake in shares of LifeStance Health Group in the fourth quarter worth $131,000. 85.50% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at LifeStance Health Group

In other news, insider Lisa K. Miller sold 18,845 shares of the company's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the sale, the insider now directly owns 339,810 shares of the company's stock, valued at approximately $2,344,689. This represents a 5.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 6.60% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on LFST. William Blair reiterated an "outperform" rating on shares of LifeStance Health Group in a research note on Friday, February 28th. Canaccord Genuity Group began coverage on LifeStance Health Group in a research report on Thursday, April 3rd. They set a "buy" rating and a $8.00 price target on the stock. Finally, KeyCorp started coverage on shares of LifeStance Health Group in a report on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 price objective for the company. One analyst has rated the stock with a sell rating, one has given a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, LifeStance Health Group has an average rating of "Moderate Buy" and a consensus price target of $8.30.

LifeStance Health Group Stock Performance

LFST traded up $0.06 during trading on Tuesday, reaching $6.59. 420,413 shares of the company were exchanged, compared to its average volume of 1,612,783. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19. The stock has a market cap of $2.53 billion, a P/E ratio of -25.37 and a beta of 1.30. LifeStance Health Group, Inc. has a 52 week low of $4.64 and a 52 week high of $8.61. The firm has a 50 day moving average of $6.96 and a 200 day moving average of $7.31.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.